Telo Genomics Corp Stock Market Value
| TDSGF Stock | USD 0.08 0.0007 0.87% |
| Symbol | Telo |
Telo Genomics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Telo Genomics' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Telo Genomics.
| 11/18/2024 |
| 12/18/2024 |
If you would invest 0.00 in Telo Genomics on November 18, 2024 and sell it all today you would earn a total of 0.00 from holding Telo Genomics Corp or generate 0.0% return on investment in Telo Genomics over 30 days. Telo Genomics is related to or competes with Grey Cloak. Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological pro... More
Telo Genomics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Telo Genomics' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Telo Genomics Corp upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 15.01 | |||
| Information Ratio | 0.0394 | |||
| Maximum Drawdown | 81.64 | |||
| Value At Risk | (19.77) | |||
| Potential Upside | 30.0 |
Telo Genomics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Telo Genomics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Telo Genomics' standard deviation. In reality, there are many statistical measures that can use Telo Genomics historical prices to predict the future Telo Genomics' volatility.| Risk Adjusted Performance | 0.0414 | |||
| Jensen Alpha | 0.685 | |||
| Total Risk Alpha | (0.54) | |||
| Sortino Ratio | 0.0388 | |||
| Treynor Ratio | (0.81) |
Telo Genomics Corp Backtested Returns
Telo Genomics appears to be out of control, given 3 months investment horizon. Telo Genomics Corp owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0307, which indicates the firm had a 0.0307% return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Telo Genomics Corp, which you can use to evaluate the volatility of the company. Please review Telo Genomics' Coefficient Of Variation of 2273.36, semi deviation of 9.22, and Risk Adjusted Performance of 0.0414 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Telo Genomics holds a performance score of 2. The entity has a beta of -0.79, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Telo Genomics are expected to decrease at a much lower rate. During the bear market, Telo Genomics is likely to outperform the market. Please check Telo Genomics' treynor ratio and the relationship between the downside variance and day typical price , to make a quick decision on whether Telo Genomics' existing price patterns will revert.
Auto-correlation | 0.39 |
Below average predictability
Telo Genomics Corp has below average predictability. Overlapping area represents the amount of predictability between Telo Genomics time series from 18th of November 2024 to 3rd of December 2024 and 3rd of December 2024 to 18th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Telo Genomics Corp price movement. The serial correlation of 0.39 indicates that just about 39.0% of current Telo Genomics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.39 | |
| Spearman Rank Test | 0.46 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Telo Genomics Corp lagged returns against current returns
Autocorrelation, which is Telo Genomics otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Telo Genomics' otc stock expected returns. We can calculate the autocorrelation of Telo Genomics returns to help us make a trade decision. For example, suppose you find that Telo Genomics has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Telo Genomics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Telo Genomics otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Telo Genomics otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Telo Genomics otc stock over time.
Current vs Lagged Prices |
| Timeline |
Telo Genomics Lagged Returns
When evaluating Telo Genomics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Telo Genomics otc stock have on its future price. Telo Genomics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Telo Genomics autocorrelation shows the relationship between Telo Genomics otc stock current value and its past values and can show if there is a momentum factor associated with investing in Telo Genomics Corp.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Telo OTC Stock
Telo Genomics financial ratios help investors to determine whether Telo OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Telo with respect to the benefits of owning Telo Genomics security.